Neuroxon, solution for injection is registered in Uzbekistan
Neuroxon, solution for injection was registered in Uzbekistan. Neuroxon is a generic drug that has proven efficacy and therapeutic equivalence to the original Citicoline.
Neuroxon is recommended to patients with acute changes in cerebral blood flow, for treatment of complications and consequences of disorders in cerebral blood flow, craniocerebral injuries and their consequences, and cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of degenerative and vascular origin. Patients who are prescribed Neuroxon receive a quality and efficacious drug that helps undergo the full treatment and rehabilitation course.
In Ukraine Neuroxon, solution for injection and Neuroxon, peroral solution were registered in 2012 and have since been actively used in medical practice. In 2013 Arterium also began marketing Neuroxon tablets in Ukraine.
Information about the drug was provided in brief form. For complete information, please refer to the instruction for use.